You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》匯豐研究下調京東健康(06618.HK)目標價至140元 評級「買入」
阿思達克 08-26 10:52
匯豐研究發表報告,指京東健康(06618.HK)上半年表現勝預期,主要由用戶增長和高質素用戶帶動,收入按年增55%,ARPU由上年同期187元人民幣升至217元人民幣。不過毛利跌1個百分點,主因產品組合變動,以及對商戶的推廣活動,經調整純利率為4.9%,勝預期。 該行指,管理層相信監管轉變是利好行業長遠健康增長,短期或會帶來不確定性,雖然情況不穩,但相信政府仍願意支持網上藥房的行業,而公司亦有能力可以助政府達至中央化和數碼化的目標。維持「買入」評級,目標價由149元降至140元,該行對集團收入及盈利預測大致不變。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account